BB
Bonita Biotech (HK) Ltd cut its ACRS stake below 5%
Bonita Biotech (HK) Ltd reported owning 4.7% of Aclaris Therapeutics, Inc. (ACRS) (7,521,300 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G